A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting
Clinical trial NCT02517021 · COMPLETED
Trial details
- NCT number
- NCT02517021
- Sponsor
- Helsinn Healthcare SA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2016-08-01
- Enrollment
- 405
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.